Webinar

FDA: Embracing Flexibility at the Agency for Advancing Innovative Therapies

In this fireside chat, “FDA: Embracing Flexibility at the Agency for Advancing Innovative Therapies,” our experts discuss the evolving landscape of regulatory frameworks at the FDA and how flexibility is crucial for the advancement of cell and gene therapies. They share insights on the importance of engaging with various stakeholders and the role of adaptive strategies in navigating the regulatory environment to bring innovative therapies to market. 

Explore how embracing flexibility and fostering collaboration with regulatory bodies can enhance the development and approval processes for innovative therapies, ultimately benefiting patients in need.

Speakers: 

  • Louis Cicchini - Director, Scientific Affairs, Cell & Gene Therapy at Cencora 
  • Celia Witten - Principal at Eliquent Life Sciences 

Fill out the form to watch the session

Pardot Form

Connect with our cell and gene experts

Schedule some time with our cell and gene experts today. We look forward to hearing from you.

Related resources

White paper

Essential guide to post-approval regulatory lifecycle maintenance
Learn more

White paper

Best practice guide: How to effectively manage local affiliate pharmacovigilance outsourcing
Learn more

Article

CGT access: Managing risk at scale
Learn more